was proposed in 2020. MAFLD is diagnosed based on hepatic steatosis and at least one of three metabolic risk abnormalities: overweight/obesity, type 2 diabetes, or evidence of metabolic dysregulation.led by Ming-Hua Zheng from the First Affiliated Hospital of Wenzhou Medical University has reported a global prevalence of MAFLD of 38.8% in adults.
A growing body of evidence suggests that MAFLD may be a risk factor for CKD. MAFLD is a condition that is characterized by the accumulation of fat in the liver. It is often associated with other conditions, such as obesity, type 2 diabetes, andA recent meta-analysis of observational studies found that people with MAFLD were more likely to develop CKD than people without MAFLD. The meta-analysis included data from over 1 million people.
The researchers found that people with MAFLD were 20% more likely to have CKD than people without MAFLD. The risk of CKD was even higher in people with more severe MAFLD. The researchers say that MAFLD could be a target for the prevention and treatment of CKD. They also say that more research is needed to confirm their findings and to understand the mechanisms by which MAFLD may contribute to the development of CKD.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: shropshirelive - 🏆 55. / 63 Read more »